Reversing aging may sound like science fiction, but scientists have already found a way to do it—at least, theoretically. Based on a 2012 Nobel-prize winning discovery, researchers are testing whether they can revert diseased cells in the eye back to young and healthy ones. They gave people a drug this year. If it works, it’ll open the door to curing and possibly preventing other age-related diseases. And that led producer Berly McCoy to wonder: Could all this research eventually extend our human lifespans? If you like this episode, check out our episodes on zombie cells, why our hair turns gray and why we die.Interested in more science on aging? Email us your question at shortwave@npr.org.Support public media with NPR+ and enjoy perks for over 25 podcasts like this one. This show’s perks include sponsor-free listening. Learn more at plus.npr.org.See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.NPR Privacy Policy
Wissenschaft & Technik
Short Wave Folgen
New discoveries, everyday mysteries, and the science behind the headlines — in just under 15 minutes. It's science for everyone, using a lot of creativity and a little humor. Join hosts Emily Kwong and Regina Barber for science on a different wavelength. Support public media by joining NPR+ at plus.npr.org. You’ll get perks for over 25 NPR podcasts, including sponsor-free listening for Short Wave.
Folgen von Short Wave
1591 Folgen
-
Folge vom 11.11.2026Can scientists reverse your age?
-
Folge vom 10.11.2026How this year's record El Niño could hit your walletPeru’s anchovy industry, the largest single-species fishery in the world, is being rocked by the ongoing El Niño . It’s not the first time the fishery has been impacted by the natural weather phenomenon — El Niño gets its name from Peruvian fishermen. And it’s a stark reminder of the reverberating economic consequences of El Niño events, which can cost the global economy trillions of dollars. Interested in more news and weather-related science? Email us your question at shortwave@npr.org.Support public media with NPR+ and enjoy perks for over 25 podcasts like this one. This show’s perks include sponsor-free listening. Learn more at plus.npr.org. See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.NPR Privacy Policy
-
Folge vom 09.11.2026An ‘Ozempic baby boom’? The GLP-1 pregnancy plot twistThe explosion of GLP-1 drugs has created a gray zone for pregnancy. That recently prompted the American College of Obstetricians and Gynecologists to issue its first ever guidance on the topic. In a twist, the drugs may boost fertility for some, leading to more pregnancies – a phenomenon known on social media as “Ozempic babies”. But doctors caution against using the drugs during pregnancy itself. In fact, the more we looked into this story, the more twists and nuances we found. So, we brought Dr. Amy Valent of Oregon Health and Science University onto the show to break down the latest on what’s known about how these drugs affect fertility and pregnancy. Interested in more health news? Email us your question at shortwave@npr.org.Support public media with NPR+ and enjoy perks for over 25 podcasts like this one. This show’s perks include sponsor-free listening. Learn more at plus.npr.org.See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.NPR Privacy Policy
-
Folge vom 05.11.2026Predicting elections is getting harder. What did the midterms teach us?Famously, polls got the 2016 election wrong. And they’d been off for multiple elections since. So, Monday night, political scientist Jack Rametta nervously refreshed his Senate forecasting model for the final time. Would it be right this time? Or would it yet again cast doubt on whether modeling, statistics and forecasting can still help us understand what motivates people to vote? Now that the results are in, so is Jack – to tell us how he did, and what his and other researchers’ predictions tell us about the evolving science of polling and forecasting.Interested in more science behind the news? Email us your question at shortwave@npr.org.Support public media with NPR+ and enjoy perks for over 25 podcasts like this one. This show’s perks include sponsor-free listening. Learn more at plus.npr.org. See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.NPR Privacy Policy